Medication adherence is a major factor to prevent vascular recurrence after a first ischemic stroke. Nevertheless, it is suboptimal and the implementation of specific interventions are needed to improve it. A patient - centered and pluriprofessional structured intervention, targeting the medication, introduced at hospital discharge and continued at home (by regular telephone contact) could improve medication adherence one year after stroke. This intervention would consist of semi structured interviews patient-pharmacist at different times during one year after stroke. The information about the therapeutic management of the patient will be shared between healthcare professionals : general practitioners (GP) and community pharmacists (CP), hospital clinical pharmacist (HCP) and physician (HPhys). It will allow for decrease of the recurrent stroke and others cardiovascular complications based on a better adherence to preventive medication. Furthermore the decrease of the iatrogenic events and the improvement of the quality of life of patients may be also associated.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Enrollment
182
Initial interview with pharmacist (at the hospital discharge): Evaluation aimed to identify barriers to adherence to drug treatment followed by an information session on the disease, the benefit of drugs and the importance of diet and lifestyle habits. Pharmacist advices focused on how to take medication and how to manage adverse events will be provided. Telephone interviews with hospital clinical pharmacist - patient (at M3 M6 and M9): The objective is to review with the patient its medication-taking routine and its potential difficulties, to motivate adherence to treatment and lifestyle/dietary rules, to give advices about therapeutics and how to take medication. HCP contacts CP to determine the prescription refill. Final interview with HCP pharmacist (at M12): The objective is to take stock with the patient about its taking drug load.
Service de neurologie vasculaire, Hôpital P Wertheimer, HCL
Bron, France
RECRUITINGService de médecine physique et de réadaptation, Hôpital Nord, CHU de Clermont Ferrand
Cébazat, France
RECRUITINGService de médecine physique et de réadaptation, Hôpital sud, CHU de Grenoble
Échirolles, France
RECRUITINGService de médecine physique et de réadaptation, Groupe hospitalier Lariboisière - Fernand Vidal, AP-HP
Paris, France
RECRUITINGService de médecine physique et de réadaptation, Hôpital Bellevue, CHU Saint Etienne
Saint-Etienne, France
NOT_YET_RECRUITINGService de médecine physique et de réadaptation, Hôpital Henry Gabrielle, Groupement Hospitalier Sud, HCL
Saint-Genis-Laval, France
RECRUITINGMeasure of patient's adherence to medication. This adherence measurement is a composite measure
A patient will be considered adherent if: 1. For each secondary-preventive drug (antiplatelet, lipid lowering, and antihypertensive), evaluated by the pharmacy refills: Number of days of medication available to the patient (supplied by the pharmacy divided by the total number of days in the period of the study (365)), is higher than 80%. 2. And score obtained from self-reported adherence questionnaire, greater than 6/8 is obtained for all secondary preventative medication
Time frame: One year after inclusion
Analysis of pharmacy refills
To estimate the benefit of the intervention on the adherence for each drug, number of days of medication available to the patient (supplied by the pharmacy) divided by the total number of days in the period of the study (365) is higher than 80%.
Time frame: 1 year after inclusion
Percentage of patients with drug-related iatrogenic events
To estimate the benefit of the intervention on the drug-related iatrogenic events, with a particular attention on the antiplatelet, VKA and the direct oral anticoagulants drugs
Time frame: 1 year after inclusion
Percentage of patients with a new stroke or cardiovascular event
To estimate the benefit of the intervention on the recurrence of stroke or another cardiovascular event
Time frame: 1 year after inclusion
Percentage of patients readmitted in hospitalization
To estimate the benefit of the intervention on the rehospitalization
Time frame: 1 year after the inclusion
Realization of a questionnaire (Likert-type scale)
To estimate the benefit of the intervention on the lifestyle risk factors
Time frame: 1 year after inclusion
Measure of glycemic and lipid balance.
To estimate the benefit of the intervention on laboratory tests
Time frame: 1 year after inclusion
Realization of a questionnaire scoring (SF-36 scale)
Estimate the benefit of the intervention on the quality of life of the patients
Time frame: 1 year after inclusion
Realization of a questionnaire (Brief IPQR)
Estimate the profit of the intervention on the representation of the disease for the patient
Time frame: 1 year after inclusion
Brief IPQR score and medication adherence (treatment adherence score and pharmacy refills) correlation (composite measure)
To measure impact of the representation of the disease on adherence to medication
Time frame: 1 year after inclusion
Realization of questionnaires (Likert-type scale and SATMED) assessment of satisfaction of patients
To estimate in each groups, the satisfaction of patients on their therapeutic follow-up, on their medication, and their relationship with the healthcare professionals (CP , GP , HCP, HPhys)
Time frame: 1 year after inclusion
Realization of a questionnaire (Likert-type scale) assessment of satisfaction of GP and CP in relation to ADMED-AVC program.
To estimate the satisfaction of general practitioners and community pharmacists concerning the ADMED-AVC's program
Time frame: 1 year after inclusion
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.